Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (4277)	3/9/1998 6:56:00 PM
From: Andreas Helke	Respond to of 9719

In rabbits the Anika anti adhesion product INCERT works better than Seprafilm. biz.yahoo.com But as you can see from those preclinical results they are still in the early development of this product. Therefore I don't think that it has much influence on the current success of Anika as a company or a stock. About anti adhesion products in general: I think that they will eventually be considered as essential part of surgery to avoid being sued by pissed off patients that have avoidable problems due to adhesion. But I am to far away from the field to have any idea when anti adhesion products will be standard. The most important product right now is probably the ORTHOVISC therapy for the treatment of osteoarthritis of the knee. There they have competition from Biomatrix (BIOX) who already has an approved product. Andreas